TL;DR
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A randomized trial involving 61 healthy adults found that a daily multi-ingredient supplement was associated with improved measures of blood vessel function and lower systolic blood pressure after six months. Only 43 participants completed both visits, and the trial did not measure cardiovascular events, so the findings do not show that the product prevents heart disease.
A six-month randomized trial found improved blood-vessel function, reduced arterial stiffness and lower systolic blood pressure among healthy adults taking a daily multi-ingredient nutritional supplement, according to a study published in European Heart Journal Open. The findings concern health markers, not heart attacks or other cardiovascular events, and the small study does not establish that the supplement prevents disease.
Researchers at the University of Surrey assigned 61 healthy adults to take either a nutritional powder containing vitamins, minerals, amino acids and plant-derived compounds, or a similar-looking powder without active ingredients. Participants took their assigned product daily for six months. Forty-three completed both study visits and were included in the primary analysis.
The team assessed several measures at the start and end of the study, including endothelial function, which reflects how well blood vessel linings work, arterial stiffness and blood pressure. It also measured lipid levels and estimated participants’ 10-year risk of a first atherosclerotic cardiovascular disease event. The researchers conducted an additional vascular assessment one hour after the first dose.
Endothelial function improved in the supplement group over six months and was largely unchanged in the control group. It also improved one hour after the first dose. Arterial stiffness fell in the supplement group and rose in the control group, while systolic blood pressure decreased significantly among those taking the supplement. There was no significant between-group difference in diastolic blood pressure, and lipid measures remained comparable.
Changes in Blood Vessel Measures
The findings matter because blood pressure, arterial stiffness and endothelial function are measures linked to vascular health and the aging of blood vessels. A result across several measures may support further study of combinations of nutrients and plant-derived compounds, rather than testing each ingredient only on its own.
But the results do not show that participants experienced fewer heart attacks, strokes or other complications. The estimated 10-year cardiovascular risk was calculated from factors including age, sex, smoking status, systolic blood pressure and non-HDL cholesterol. The researchers said the small change in estimated risk between groups was driven mainly by the difference in systolic pressure; the trial did not observe actual cardiovascular events.
The study therefore offers early clinical evidence about measurable indicators, not proof of a preventive treatment. Its size and duration limit how much can be concluded about lasting effects or benefits for people with diagnosed cardiovascular conditions.
Products Worth Considering
Withings BPM Connect Blood Pressure Monitor with Wi-Fi and Bluetooth
Fitbit Sense 2 Health and Fitness Smartwatch, Shadow Grey/Graphite
Philips Sonicare ProtectiveClean 5300 Rechargeable Electric Toothbrush with 3 Brush Heads, Black
As an affiliate, we earn on qualifying purchases.
Why Researchers Tested a Combination
Vascular aging involves gradual changes in blood vessel structure and function. The report describes endothelial dysfunction, increased arterial stiffness and higher blood pressure as markers associated with that process. Researchers point to several interacting biological mechanisms, including oxidative stress, low-grade inflammation, mitochondrial dysfunction and changes in nitric oxide availability.
Some bioactive compounds, including polyphenols, amino acids and micronutrients, have been studied for effects relevant to vascular function. Much of the earlier research considered compounds individually. The Surrey team said evidence in humans for multi-compound interventions remains limited, leaving open whether combining ingredients that target different pathways can produce added benefits.
The trial compared a multi-ingredient product with a matched powder lacking active ingredients. The report does not provide a basis for treating the findings as evidence for any particular nutrient alone, or for assuming that other supplements with different formulations would have the same effects.
“The clinical evidence supporting multi-compound interventions in humans is limited.”
— The study authors, as described in the report
Limits of the Trial Evidence
Forty-three of 61 participants completed both study visits and contributed to the primary analysis. The available report does not explain in detail why the other participants did not complete follow-up, or provide enough information here to assess how their absence may have affected the results.
The source material does not give the supplement’s full ingredient list, the quantities of each component, the size of the measured changes, or detailed adverse-event findings. It also does not establish whether the vascular changes would persist after participants stopped taking the product. Those details are needed to judge the results and their relevance to particular people.
The participants were described as healthy adults. The findings cannot automatically be applied to people with cardiovascular disease or other health conditions. The trial did not assess actual heart attacks, strokes, mortality or long-term safety, and it cannot establish that taking the supplement lowers an individual’s risk of disease.
Larger Studies Needed
The authors said the results need testing in larger, longer clinical trials. Follow-up research would need to establish whether the changes are consistent, how long they last, whether the supplement is safe over longer periods and whether any benefit extends to cardiovascular outcomes rather than intermediate measures.
The report does not identify a planned next trial or a timetable for further results. Until stronger evidence is available, the study should be read as a preliminary finding about vascular markers, not as a recommendation to start a supplement or replace prescribed care. People considering supplements for health reasons can discuss their circumstances with a qualified health professional.
Key Questions
What did the trial find?
Among the 43 participants included in the primary analysis, the supplement group showed improved endothelial function, lower arterial stiffness and reduced systolic blood pressure over six months. The study did not find a significant difference in diastolic pressure, and lipid levels remained comparable between groups.
Did the supplement prevent heart disease?
No such conclusion can be drawn. Researchers measured vascular markers and estimated risk; they did not track heart attacks, strokes or other cardiovascular events during the trial.
How many people completed the study?
The trial enrolled 61 healthy adults. Forty-three completed both study visits and were included in the primary analysis.
Can the results be applied to other supplements?
Not on the evidence reported. The study tested one multi-ingredient powder, and the source material does not provide its full formulation and doses. Products with different ingredients may not have the same effects.
What research is needed next?
Larger and longer trials are needed to test whether the reported changes hold up, persist over time and translate into meaningful health outcomes. Long-term safety also remains to be established.
Source: news-medical.net
